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Sensing what’s Important: determining parental preferences of children with Hunters 
Syndrome/Sanfilippo Syndrome for when they are receiving treatment in hospital. 
Introduction 
Introduction 
This article explores the opinion of parents when interviewed about their child’s senses (any of the 
faculties by which stimuli from outside or inside the body are received and felt, e.g. hearing, sight, 
smell, touch, taste, and equilibrium) with the aim of making their child’s stay in hospital more 
successful and thereby reduce any behaviours of concern which make it difficult for nurses to 
effectively treat the child or young person. The aim of this article is to explore perceptions about 
using the ‘stress sensory preferences interview and recommendations evaluation’ (SsPIRE) to elicit 
this information. This includes understanding the form and questions covered within the profile, 
how this can impact upon the care provided once strategies most appropriate for their child have 
been recognised and confidence in staff to think proactively about plans for sensory care and 
managing behaviours of concern.  
 
Behaviours of concern may prove difficult for nurses to manage a child’s quality of care and the 
intensity of such behaviours can put parents, carers and nurses at risk of injury (Page and 
McDonnell, 2013; Chan et al, 2011; McDonnell, 2010). Many children diagnosed with life limiting 
conditions may display behaviours of concern when receiving medical care from healthcare 
professionals (Page et al, 2015).  
 
The National Institute for Health Research/Wellcome Trust Clinical Research Facility (NIHR/CRF) at 
Birmingham Children’s hospital supports the delivery of academic and commercial research studies, 
enabling children and young people to take part in high quality, safe and ethically approved clinical 
research. In supporting clinical research the NIHR/CRF aims to improve clinical care and the lives of 
children, young people and their families. Many of the children and young people undertaking such 
clinical research are doing so because they have a life limiting medical condition which often 
includes conditions and syndromes which gives rise to conditions and syndromes which challenge 
healthcare practitioners when they are administering medical care (Page et al, 2015). Some of the 
children and young people visiting the NIHR/CRF have disabilities and traits of autism as part of their 
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condition, for example those with Hunters Syndrome or Sanfilipo Syndrome. See Glossary for 
information about Hunters Syndrome and Sanfilipo Syndrome 
 
There are a vast number of websites and resources offering standardised forms and checklists but 
none offered the level of insight required to improve the quality of care for the child or young 
person within the hospital setting. With this in mind we developed a stress sensory preferences 
interview and recommendations evaluation (SsPIRE) which was trialled within the NIHR/CRF 
between November 2015 and May 2016.  
 
The authors developed SsPIRE as a result of their experiences of working within this field, noting key 
information to understand and support individuals who display behaviours of concern and have 
sensory difficulties.  Therefore, their knowledge, understanding and perceptions of an assessment 
profiling tool such as the SsPIRE was required to gather data on how practical this profile is to 
implement into a ward setting. The parents feelings about their child being in hospital undergoing 
treatment can also influence their child’s reactions and behaviours when receiving treatment. 
Therefore it was important to evaluate parents’ perceptions of the stress sensory preferences 
interview and recommendations evaluation (SsPIRE), not just those of the nursing team. 
 
This article is part of a series funded by the NIHR Wellcome Trust using qualitative research to 
develop best practice on holding and providing treatment to children with behaviours that challenge 
for clinical procedures and inform policy development. 
 
Methods 
This study was conducted at the National Institute for Health Research/Wellcome Trust Clinical 
Research Facility (NIHR/CRF) at Birmingham Children’s Hospital. In supporting clinical research the 
CRF aims to improve clinical care and the lives of children, young people and their families. The unit 
opened in 2008 and currently has 107 active studies, with four Hunters Syndrome and Sanfilippo 
Syndrome trials taking place. 
 
Ethical approval was gained prior to the commencement of this work from Birmingham City 
University Ethics Committee and Birmingham Children’s Hospital Research and Development 
Strategic Committee. 
 
Participants in this study were parents of children receiving treatment on the unit between February 
and May 2016. Only parents whose children had Hunters or SanFilippo Syndrome were asked to take 
part. Four mothers and one father volunteered, which provided 100% uptake from the eligible 
participant group. In order to preserve the principles of a least intrusive approach, it was considered 
appropriate for the authors to not observe the interaction between the clinical research nurse and 
parents when SsPIRE (version 1) was being completed, despite the obvious advantages of such.  Also 
the highly confidential nature of clinical trials taking place would not be jeopardised.   
 
The authors (AP, AM and CG) produced a semi structured interview script to evaluate the ease of 
completion, the sensory topics and questions covered within the profile, and how this can impact 
upon the care provided once strategies most appropriate for that child or young person have been 
recognised. Please see interview script 
 
Thematic analysis was utilised, which is a useful method for identifying, analysing and reporting 
patterns (themes) within data (Braun and Clarke, 2006). This approach can also generate 
unanticipated insights and due to the limited research on using sensory profiles in this area, this was 
viewed as an advantage.  Finally, as noted by Braun and Clarke, this approach is also beneficial for 
analysis informing policy development, which is an ultimate aim of this research. Primary analysis of 
the semi structured interviews was completed by all the authors, where the data was examined and 
certain points highlighted, such as noting contradictions, consistencies and common themes. AP, CG, 
PA reviewed all transcripts again to develop a rich thematic description of the entire data set and 
identify predominant themes. The authors organised the data into meaningful groups of interesting 
patterns (coding) manually. Themes were identified through mind mapping. AM joined the group to 
review, define and name the themes. 
 
Results/findings 
Three overarching themes were generated; person-centred planning, confidence and interview 
amendments. 
Person centred planning.  
“Person Centred Planning discovers and acts on what is important to a person. It is a process 
for continual listening and learning, focussing on what are important to someone now and in 
the future, and acting on this in alliance with their family and their friends” (Thompson, 
Kilbane and Sanderson, 2008:27). 
With this in mind parents commented that they thought the SsPIRE was able to separate out what is 
important to the child or young person from what is important for them, and to find a balance for 
when they are receiving treatment in hospital. 
Parent 4 “My son does not like to wear shoes and will not put on a hospital gown”. 
Parent 1 “You are wanting to get a better idea of the patient…so do they prefer to be active 
vast majority of times yes...but in this kind of environment not so much” 
As a framework, parents thought that the SsPIRE encouraged nurses to be thinking about their 
child’s care. In particular they felt that this process would be valuable for new patients in the unit or 
if their child was receiving treatment elsewhere in the hospital. 
Parent 1 “This tool would be great for example if he’s having an op somewhere else in the 
hospital and he’s going off to somebody who doesn’t know him well…this would be a great 
tool as a handover kind of package for them to be able to see” 
Parent 3 “My son goes to several wards, hopefully this form will mean that all the nurses 
work together and do the same thing” 
 
Parents also suggested that the SsPIRE would be valuable to identify nurse training needs and 
further equipment that could be purchased. 
Parent 2 “I mean things like visual prompts like signs and symbols used in schools...he uses 
those and then obviously here he hasn’t got those… so just like a basic signs and symbols 
package would probably work quite well for him because none of the children with my child’s 
illness have got communication or Makaton abilities, none of them…..so that would probably 
benefit the staff here” 
Parent 5 “The role of sensory play is often left to parents on the ward …this form suggests 
that the nurses have a bigger role in this” 
The parents commented that the SsPIRE asked questions that they had not been asked before. One 
of the goals of the SsPIRE was to synthesise and organise the questions and responses so that it 
describes not only what is important to and important for each child or young person but also 
describes the balance between them ensure ‘a good day’ when they receive treatment on the unit, 
but also to minimise incidences of behaviours which challenged or interrupted treatment. Therefore 
whilst surprising to know that parents had not been asked certain questions before, it was 
reassuring to realise that the questions were viewed as important by the parents. 
 Parent 2 “I don’t think we have ever been asked about touch, balance and body awareness” 
Parent 1 “Yeah...a lot of them … do they like messy hands and that sort of thing I have not 
been asked before” 
Parent 5 “It was good for questions on balance like does my son seek motion and what that 
actually means for him” 
Our experience in using a similar approach to the SsPIRE with children and adults with a learning 
disability suggested that the use of the tools would encourage sharing of information. We were 
pleased to note that this was also identified by the parents and prompted them also to think about 
introducing strategies into the unit. 
Parent 1 “I would share it with staff at the hospice they have a play worker so it would be 
good if she could have a copy and input into it as well” 
Parent 2 “I’d share it with school I’d put it in his as part of his care plan… (my child) had quite 
an in depth sensory input through his OT back at home. He’s had the weighted blankets, vest, 
he’s got quite a few different things…but I would never have thought about bringing those 
kind of activities into this situation where actually it probably would have helped him” 
 
Confidence 
Parents perceived that by using the SsPIRE led them to feel more confident is the ability of the 
nurses to care for their child. 
Parent 4 “made me have more confidence my son’s needs will be looked after and 
addressed” 
In this article we have highlighted the difficulties these children and young people have interacting 
with others, expressing their needs, likes and dislikes. One parent felt that the SsPIRE form would 
improve her child’s confidence in communicating to others as this form would help others to 
understand his needs. 
 
Interview Amendments 
All interview data are open to interpretation, which is why it is important to undertake a trial and 
examine people’s interpretation and viewpoints to enable modifications to take place. The parents 
asked if there could be a variable section within the questions to recognise that their child may 
behave differently dependent upon their mood. 
Parent 3 “There were a few questions where he was between a yes and a no. One on for 
example does physical activity distress or relax them or have no known effect…depending on 
his mood it can relax or it can stress him ” 
Parent 2 “The only thing that I would point out is that the communication section is a very 
tricky one because in the main they have no verbal communication….they can’t tell you what 
they want…it’s a power of dedication type of thing...so the communication section is a really 
difficult one and could probably do with being expanded a little bit ” 
Parent 4 “Possibly need additional questions about clothing…my son does not like to wear 
shoes and he will not wear a hospital gown ” 
 
Discussion 
Thematic analysis yielded three main themes: person-centred planning, confidence and interview 
amendments when utilising this profile for the future. Parents appeared to find this form useful and 
empowering, stating it was easy to use and the questions allowed for positive information gathering, 
which promotes greater person-centred care. Thus, the SsPIRE appears to have good face validity 
and produce useful information on sensory experiences. It should be noted that the sample size for 
this study is small. However the setting of the NIHR/CRF being a highly specialised department 
means that a large sample size would be difficult to achieve.  
 It has been documented that individuals with an intellectual disability and/or traits of autism may 
process and experience sensory information differently to their peers without disabilities (Mefford 
et al, 2012; Thomchek and Dunn, 2007). Such difficulties may be highlighted more so when there is 
an increase in stress levels due to visiting hospital and receiving medical procedures. The behaviours 
of concern healthcare practitioners can include aggression, self-harm, destructiveness and 
disruptiveness.  Children with behaviours such as these are also at risk of being denied access to in-
patient, acute and emergency care treatments as the intensity of their behaviours puts them, 
parents/carers and healthcare staff at perceived risk of injury. This can lead to poorer quality of life 
and on-going health problems as treatment(s) may have been omitted or the results are not as 
effective (Page and McDonnell, 2013).  These behaviours of concern are often seen in children with 
conditions that effect ‘communication’ and the ‘brain’, for example learning disabilities and more 
rare conditions such as Hunters Syndrome and Sanfilippo Syndrome. Communication is the main 
way we interact and express our needs, likes and dislikes. If communication is a problem then it can 
be very frustrating for the child and may result in behaviours of concern. Being in hospital can create 
stressful and anxiety emotional states which children may have limited coping abilities for (Wright, 
1995). The treatment required for children and young people with Hunters Syndrome and Sanfilippo 
syndrome can be highly invasive and this information has been developed to assist and clarify key 
behaviours of concern. The nurses working within the NIHR/CRF are highly specialised and tend to 
see these children at intervals during their treatment process. SsPIRE has led to a changing in 
thinking from parents and healthcare staffs perspective- sorting what is important to the child from 
what is important for them within the hospital setting, and then looking for a balance between these 
two perspectives. The NIHR/CRF nursing team recognise that all too often this is not the reality of 
how services and professionals operate. Therefore the SsPIRE could also be a tool to facilitate 
teaching of this skill and so that identifying the balance between what is important to the child from 
what is important for them within the hospital setting becomes a habit for nursing staff. 
 
SsPIRE follows the general principles of care identified within The NICE Guidelines (2015) in that it 
takes into account the child’s learning disability, their communication needs and sensory needs in 
order to improve their quality of life when receiving treatment in hospital, and identifies sensory 
strategies to calm the child down or to divert them when they are demonstrating signs of distress. 
NHS England is committed to making sure that people with a learning disability and/or autism who 
display behaviours of concern receive the right care in the right settings, with the right support. The 
feedback from parents is that SsPIRE will assist in improving the care given towards their child in 
hospital and their own confidence in healthcare staff to manage their child’s behaviours. Further 
research is needed to determine whether this greater emphasis on admission and the 
communication pathway may have appositive impact upon the treatment process. In addition, 
involving parents in this process at an early stage may lead to the development of more positive 
working relationships with healthcare staff. Given statistics about the numbers of children affected 
by autism, the association of stress and sensory issues, future research needs to look at introducing 
bespoke autism training for nurses and evaluating the impact upon the care given. 
 
Other relevant research currently being undertaken within the NIHR/CRF  
Through the NIHR/CRFs sixth formers research programme additional supporting research has been 
developed and undertaken; the ‘Sense not Stress study’, designed by sixth formers explores the 
theory that using sensory equipment can alleviate anxiety in children and young people attending 
for clinical appointments and undergoing clinical procedures, creating a more personalised and 
positive experience for children and young people attending the facility. The study findings have 
highlighted the need for further research with the potential linkage to the sensory assessment 
profile (SsPIRE) to provide a wider data capture set, to assist in profiling and provision of equipment 
placement, and pathways for children visiting the facility especially for those children having sensory 
challenges.  
A study has also been conducted investigating the perceptions of nursing staff using the SsPIRE in 
the same unit as the present study. Staff reported that the use of form has reiterated and increased 
their understanding of sensory processes and noted how this form promotes a person-centred 
approach for their patients. Using feedback from both nursing staff and parents we are now in the 
process of disseminating SsPIRE for use with children who have been identified. 
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Interview Script – Sensory assessment forms (Parents) 
Q1. Were there any questions you didn’t understand being on the form? 
Q2. Can you think of any additional questions that should be asked? 
Q3. Were there any questions you hadn’t been asked before with regard to hospital visits? 
Q4. Has the use of these questions impacted on your confidence in the care given when visiting this 
unit? 
Q5. If you were to have a copy of this form, who would you think about sharing it with? 
Q6. Has using this form prompted you to think more proactively about plans for sensory care than 
before? 
Q7. If your child has been visiting the unit prior to November 2015, has using this form and the sensory 
room impacted your visits to the unit? 
Diagram Click here to download Diagram interview guide for Parents (Box
1).docx
Glossary 
Hunters syndrome (mucopolysaccharidoses MPS II) is a disease in which long chains of sugar 
molecules (mucopolysaccharides) are not broken down correctly and build up in the body.  It’s an 
inherited condition where mainly boys are affected. The condition is caused by a lack of the enzyme 
iduronate sulfatase and without this enzyme, mucopolysaccharides build up in various body tissues, 
causing damage. The early-onset, severe form of the disease begins shortly after age 2. A late-onset, 
mild form causes less severe symptoms to appear later in life.  Over a ten year period between 1992 
and 2002, 52 babies with Hunters Syndrome were born in the UK. 
Juvenile form (early-onset, severe form) can lead to spasticity, aggressive behaviours, hyperactivity, 
declining mental functioning over time and severe intellectual disability. A late (mild) form can lead 
to mild to no mental deficiency (Muenzer, Wraith & Beck, 2006). 
 
Sanfilippo syndrome (mucopolysaccharidoses MPS III) is an inherited, autosomal recessive, 
metabolism disorder that where the body is unable to effectively break down long chains of sugar 
molecules called glycosaminoglycans.  Sanfilippo syndrome occurs when the substances (enzymes) 
needed to break down the heparan sulfate sugar chain are missing or are defective. There are four 
main types of Sanfilippo syndrome, which type a person is depends on which enzyme is affected. 
Approximately 1 in 70,000 births are affected by Sanfilippo syndrome.  The symptoms often appear 
after the first year of life.  This can be characterised by a decline in learning ability typically occurring 
between ages 2 and 6. Delayed development is followed by deteriorating mental status and 
associated behavioural problems.  These children can suffer significant neurological symptoms which 
include severe intellectual disability.  These symptoms unfortunately mean that these children have 
servere challenging behaviours that parents, careers and health care providers have to deal with in 
order to look after the children (Muenzer, Wraith & Beck, 2006).  
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       Oliver (MPS IIIC)
What is Sanfilippo Disease?
Sanfilippo Disease is a Mucopolysaccharide storage 
disorder, also known as Mucopolysaccharidosis Type III. 
The disease takes its name from Dr. Sanfilippo 
who was one of the first doctors from the United States 
to describe the condition in 1963.
Whilst there is no cure for individuals affected by 
MPS III, this factsheet explores the presentation and 
clinical management of the disease. 
This factsheet is produced by the Society for 
Mucopolysaccharide Diseases 
(MPS Society) drawing on the experiences of parents 
and doctors with reference to medical literature.
What Causes Sanfilippo Disease? 
Mucopolysaccharides are long chains of sugar molecules 
used in the building of bones, cartilage, tendons 
and many other tissues in the body. “Muco” refers 
to the thick jelly-like consistency of the molecules, 
“poly” means many and “Saccharide” is a general term 
for the sugar part of the molecule.
An alternative word for Mucopolysaccharides 
is glycosaminoglycans (or GAGS) but the term 
Mucopolysaccharides will be used for continuity 
throughout this Factsheet.
In the course of normal life there is a continuous recycling 
process of building new Mucopolysaccharides 
and breaking down old ones. This process requires a series 
of biochemical tools called enzymes. 
Individuals with MPS III are missing an enzyme which 
is essential in cutting up the used Mucopolysaccharides. 
Incompletely broken down Mucopolysaccharides remain 
stored inside parts of the cells called lysosomes. 
The lysosomes become swollen and disrupt cell 
functioning causing progressive damage. 
Babies may show little sign of the disease but symptoms 
start to appear as more and more cells become damaged 
by the accumulation of Mucopolysaccharides.
Are There Different Forms of Sanfilippo 
Disease?
To date, four different enzyme deficiencies have been 
found to cause MPS III and thus the condition is described 
as MPS III Type A, B, C or D. Type A is the most common 
form found in most populations.
• MPS III A is missing the enzyme heparan N sulphatase
• MPS III B is missing the enzyme alpha-N-
   acetylglucosaminidase
• MPS III C is missing acetyl-CoA:alpha-glucosaminide    
   acetyltransferase
• MPS III D is missing N-acetylglucosamine-6-sulphatase
It is important to note that there are no significant, 
clinical, physical differences between the different 
subtypes of MPS III disease, although there have been 
cases of late onset MPS III Type B where the individuals 
have remained relatively unaffected into adult life. 
The latest understanding is that some people seem 
to produce some enzyme activity which helps to slow 
down the progression of the disease whilst those with 
more severe symptoms appear to have no enzyme 
activity at all.
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Night blindness 
Many families have reported that children with 
Sanfilippo Disease do not want to walk in the dark 
or are afraid when waking up at night. Determining the 
reason for this problem is difficult. 
Putting a night light in a hall or bedroom may prove 
beneficial. 
How Common is Sanfilippo Disease?
The MPS Society, which co-ordinates the Registry 
for Mucopolysaccharide and Related Diseases, has shown 
that MPS III is a rare condition affecting one in 85,000 live 
births. Over a ten year period between 1988 and 1998, 
97 babies were born with MPS III in the United Kingdom.
How is Sanfilippo Disease Inherited?
MPS III is an autosomal recessive disease whereby 
both parents must carry the same defective gene 
and each pass this same defective gene to their child. 
Where both parents are carriers of the MPS III gene there 
is a 25% (1:4) chance of having an affected child in each 
pregnancy. There is a 50% (1:2) chance of a child receiving 
only one copy of the defective gene and therefore being 
a carrier. A carrier will not be affected but can pass the 
defective gene to his/her offspring. The remaining 25% 
(1:4) will be neither affected nor a carrier. 
Using information from an affected individual’s DNA, 
it may be possible to determine whether brothers 
and sisters are carriers of, or if they are affected 
by MPS III.
Can you Test for Sanfilippo Disease 
in Pregnancy?
For each pregnancy the chances of a baby inheriting 
MPS III are totally independent of whether a previous 
child was affected by MPS III. Pre-natal tests can be 
arranged early on during a pregnancy for those families 
who already have a child with MPS III. Both amniocentesis 
and chorionic villus sampling can be used to diagnose 
MPS III in utero.
Genetic Counselling
All parents of children with a lysosomal storage disease 
should consider asking for genetic counselling before having 
other children. The counsellor should be able to advise 
on the risk to close relatives and to suggest whether 
the wider family should be informed.  
Clinical Presentation of Sanfilippo Disease
Physical Appearance
Children with MPS III grow to a fairly normal height 
and changes in appearance may be less than in other 
MPS diseases. The hair is thick and coarser than usual 
and their bodies may be hairier than normal. The eyebrows 
are often dark and bushy and may meet in the middle. Noses 
tend to be upturned and flat on the bridge.
Physical Problems
Of all the MPS diseases, MPS III produces the mildest physical 
abnormalities. It is important, however, that simple 
and treatable conditions, such as ear infections, are not 
overlooked because behavioural problems make examination 
difficult. Parents may need to search until they find a doctor 
with the patience and interest in treating a child with 
a long-term condition. Do not hesitate to consult your doctor 
if you think your child may be in pain.
Intellectual Ability 
Whilst the majority of children affected by MPS III will loose 
their intellectual ability progressively through childhood, 
a small number may retain intellectual skills into adulthood. 
Neurological Problems 
During the later stages of MPS III some children may 
experience seizures. Seizures are as a result in disruption 
in the electrical activity in the brain, which may also be 
referred to as epilepsy or fits.
Eyes
Corneal clouding does not occur in the eyes as it does in 
other MPS diseases.
Ears 
Some degree of deafness is common in individuals suffering 
from all types of MPS III. It may be Conductive Deafness, 
Nerve Deafness or both (Mixed Deafness) and can be made 
worse by frequent ear infections. 
It is important that individuals with MPS III have their 
hearing checked regularly and for problems to be treated 
early to improve or maintain the ability to communicate 
and learn. 
Conductive Deafness is concerned with impaired 
transmission of sound waves through the ear canal, the ear 
drum and the middle ear. Correct functioning of the middle 
ear depends on the pressure behind the ear drum being the 
same as that in the outer ear canal and the atmosphere. 
This pressure is equalised by the eustachian tube which runs 
from the middle ear to the back of the nose. If the tube
is blocked the pressure behind the eardrum will drop, 
the drum will be drawn in and the transmission of sound 
waves will be impaired.
Seizures/Epilepsy
At a later stage of the disease a number of children 
with MPS III will start to have frequent, minor seizures 
when they momentarily alter their level 
of consciousness (absences). This could be a stare 
for a few seconds, lack of response or a slight twitch. 
On days when this occurs the child may seem more 
out of touch or harder to feed. Some may have more 
generalised seizures (grand mal) involving either loss 
of consciousness or physical jerking. 
During the seizure you should place your child 
on his or her side to prevent the inhalation of vomit. 
The child should be left in that position until the 
seizure is over. You should check that the airway 
is clear but do not put anything in the child’s mouth. 
Both forms of seizure can be treated with medication 
if indicated. Sometimes this may involve a number 
of drugs and the child may be drowsy until they become 
used to the medication.
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If this negative pressure persists, fluid from the lining of the 
middle ear will build up and in time become thick like glue. 
Hence the condition being reffered to as “glue ear”. 
Heart
It is generally accepted that the heart is not usually 
affected by the disease.
Nose & Throat
The problems described in this section are common 
to children with MPS diseases but occur less often in 
individuals with MPS III. The severity of the problem 
depends greatly on the individual child. 
Frequent coughs, colds and throat infections are common 
problems. The tonsils and adenoids often become 
enlarged and can partly block the airway. For this reason 
they may be removed (See breathing difficulties).
The neck is usually short which contributes to the 
problems in breathing. The windpipe (trachea) becomes 
narrowed by storage material and is often more floppy, 
or softer than usual, due to abnormal cartilage rings in 
the trachea. Nodules or excess induration of tissue can 
further block the airway. 
Typically, the bridge of the nose is flattened and the 
passage behing the nose is smaller than usual due to poor 
growth of the bones in the mid-face and thickening of the 
mucosal lining. 
The combination of abnormal bones and storage 
of Mucopolysaccharide in the soft tissue can cause 
the nose to become easily blocked. Some children with 
MPS III can have chronic discharge of clear mucus from 
the nose (rhinorrhea) and sinus infections. 
Mouth & Teeth
The lips are thick, the gum ridges are broad and the 
tongue becomes enlarged. Teeth are widely spaced 
and poorly formed with fragile enamel. It is important 
that the teeth are well cared for as tooth decay could 
be a cause of pain.
Breathing Difficulties
Children with MPS III may breathe very noisily, even when 
there is no infection. At night they may be restless 
and snore. Sometimes the child may stop breathing 
for short periods while asleep (sleep apnoea). 
This noisy breathing, which stops and starts, can be very 
frightening for parents to hear and they may fear that 
their child is dying. In fact many children may breathe 
like this for years. Many children with MPS III have 
frequent colds, blocked noses and chest infections. 
This may be managed using C-PAP. 
Conductive Deafness (Glue ear)
Under general anaesthetic a small incision behind 
the eardrum can be made (myringotomy) 
and the fluid sucked out. A small ventilation tube called 
a “grommet” may then be inserted to keep 
the hole open and allow air to enter from the outer ear 
canal until the eustachian tube starts 
to work properly again. Grommets will eventually 
fall out. If the conductive deafness recurs T-tubes 
may be used. T-tubes are a type of grommet which stay 
in place longer. Due to the anaesthetic risks 
for individuals with MPS III, the surgeon may decide 
to use T-tubes on the first occasion. 
Sensoineural Deafness (Nerve Deafness)
In most cases the cause of Nerve Deafness 
is damage to the tiny hair cells in the inner ear. It may 
accompany Conductive Deafness, in which case it is 
referred to as “Mixed Deafness”. 
Nerve Deafness is managed by the fitting of hearing 
aids. Children with MPS III may keep pulling 
out their hearing aids at first but it is important 
to persevere at wearing them so that communication 
can be maintained.
Respiratory Infections
Medication may affect individuals with MPS differently 
so it is essential to consult your doctor rather than using 
over the counter medication. Decongestants usually 
contain stimulants that can raise blood pressure and 
narrow blood vessels, both of which are undesirable 
for individuals with MPS III. Cough medicines that have 
a sedating effect may cause more problems with sleep 
apnoea by depressing muscle tone and respiration. 
Individuals with MPS III may end up with secondary 
bacterial infections which should be treated 
with antibiotics.
Dental Hygiene
Teeth must be well cared for to avoid the need 
for extractions. If the water in your area 
has not been treated with fluoride then your child 
should have fluoride tablets or drops daily. Cleaning 
around the mouth with a small sponge or a stick 
coated in mouthwash will help keep the mouth fresh 
and avoid bad breath. 
It may be safer for any treatment to be carried 
out in hospital. If teeth need to be removed under 
anaesthetic this should be carried out in hospital under 
the care of an experienced anaesthetist 
and never in the dental surgery.
Dribbling is a common problem and a plastic backed 
bib under the clothes may prevent soreness.
Liver, Spleen & Abdomen
The liver and spleen may be slightly enlarged due 
to the storage of Mucopolysaccharides 
(hepatosplenomegaly). The enlarged liver does 
not actually cause problems or lead to liver failure 
but its volume can interfere with eating and breathing. 
Skin
Individuals with MPS III tend to have thickened and tough 
skin which lacks elasticity. Excess hair on the face 
and back occurs in some individuals.
             
Bones & Joints
Bones
Individuals with MPS III tend to have minimal problems 
with bone formation and growth.
Joints
Joint stiffness is common in all MPS diseases. 
All the joints become stiff and their movement  
may become limited. Later in the child’s life this 
can cause pain which may be relieved by warmth 
and ordinary pain killers. The limited movement 
in the shoulders and arms may make dressing difficult. 
Legs and Feet
Many individuals with MPSIII stand and walk with their 
knees and hips flexed. Combined with the tight Achilles 
Tendon this may cause them to walk with their toes 
curved under, rather like the hands. 
Hands
The fingers of children with MPS III occasionally become 
bent over (clawed) and the arms may not be able 
to extend fully. Later on there may be some limitation 
of movement in the large joints such as shoulders, 
elbows, hips or knees.
Hips
Individuals with MPS III may suffer from dislocated 
hips but treatment may not be advisable or necessary. 
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Hip Disease
Many children with MPS III have periods of limping 
or apparent pain in their hips. If an X-Ray is taken 
it is often thought that they have a condition called 
Perthes’ Disease. The changes seen are in fact very 
common with MPS III and are probably part of the bone 
disease that occurs in all children with the disease.
Night Time C-PAP
(Continuous Positive Airway Pressure)
A Night Time C-PAP may be recommended where 
a sleep study has shown that an individual 
is experiencing sleep apnoeas. This is where the 
individual suffers from low oxygen levels at night 
and stops breathing for short periods, leading to day 
time drowsiness and headaches.
C-PAP involves placing a mask or canula on the face 
each night and having air pumped into the airway 
to prevent it from collapsing. This may seem to be 
an extreme measure but it can greatly improve the 
quality of sleep and help prevent or reduce the risk 
of heart failure caused by low oxygen levels at night. 
In severe cases of sleep apnoea with heart failure, 
a tracheostomy (a hole in the airway made in front 
of the neck) may be needed. Those who have received 
an early tracheostomy claim to feel much better after 
improving their night time breathing.
Bowel Problems 
Many individuals with MPS III suffer from loose stools 
and diarrhoea. Occasionally it is caused by severe 
constipation and leakage of loose stools from behind 
the solid mass of faeces. However, parents often 
describe it as “coming straight through”. It is thought 
there may be a defect in the autonomic nervous system 
which controls those bodily functions usually beyond 
voluntary control. Examination by a paediatrician 
or physician supplemented by an X-Ray if needed will 
establish the cause. 
This problem may disappear as the child gets older 
but it can be worsened by antibiotics prescribed 
for other problems. If there is diarrahoea 
(and it is not secondary to constipation) simple 
medication, such as loperamide (Immodium) can be very 
useful. A diet low in roughage may also be helpful. 
Constipation may become a problem as a child gets 
older and becomes less active, resulting in the muscles 
weakening. If an increase in roughage in the diet does 
not help or is not possible, the doctor may prescribe 
laxatives or a disposable enema.
Progression of Sanfilippo Disease
The disease will affect children differently 
and its progress will be much faster in some cases more 
than others. Change will usually be very gradual 
and therefore easier to adjust to. There could also 
be periods where there is a significant amount of change 
all at once, followed by a period of time where the rate 
of these changes slows down considerably. This is referred 
to as a plateau stage. The disease tends to progress 
through the following stages:
The First Stage
The first stage takes place during a child’s pre-school 
years. This may be a very frustrating time for the parents. 
They begin to worry as their child starts to lag behind 
their friends’ children in development and they may feel 
that they are being blamed for the child’s overactive and 
difficult behaviour. The diagnosis is often made very late 
due to the fact that some children do not look different in 
any way and their symptoms (such as diarrhoea, frequent 
respiratory and ear infections as well as boisterous 
behaviour) are among the most common seen in all 
children. The doctor has to be perceptive enough to 
recognise that something serious is wrong and to ask for 
urine and blood tests to help reach a diagnosis. It is not 
unusual for families to have had more than one affected 
child before the diagnosis is established.
The Second Stage
The second phase of the disease is characterised 
by extremely active, restless and often very difficult 
behaviour. Some children sleep very little at night. 
Many will be into everything. Many like to chew hands, 
clothes or anything they can get hold of. Sadly, language 
and understanding will gradually be lost and parents may 
find it hard not being able to have a conversation with 
their child. Many will find other ways of communicating, 
perhaps by using sign language such as the Makaton 
System. Some children never become toilet trained 
and those who do will eventually lose this ability.
The Third Stage
In the third phase of the disease children with MPS III 
begin to slow down. They become unsteady on their feet 
and tend to fall frequently as they walk or run. 
Eventually they will lose the ability to walk. 
Life may be more peaceful in some ways but parents 
will need help with the tiring physical aspects of caring 
for an immobile child or teenager. Parents will also need 
to be advised on how best to cope with these changes 
so they are equiped and able to provide their child with 
the best care possible.
General Management of Sanfilippo Disease 
Anaesthetic
Giving an anaesthetic to an individual with MPS III requires 
skill and should always be undertaken by an experienced 
anaesthetist. Where a child is concerned this should 
be a paediatric anaesthetist. 
The airway can be very small and may require a very 
small endotracheal tube. This is a tube that is inserted 
into the trachea through the mouth or nose in order to 
maintain an open air passage to deliver oxygen 
or to permit the suctioning of mucus. Placing this tube 
may prove difficult and require the use of a flexible 
bronchoscope. In addition, the neck may be somewhat 
lax. Repositioning the neck during anaesthesia 
or intubation could cause injury to the spinal cord. 
For some individuals, it is difficult to remove the 
breathing tube after surgery is completed. 
There is a more detailed explanation of this complex 
subject in the specialist anaesthetic booklet published by 
the MPS Society.
Physiotherapy & Hydrotherapy
Both physiotherapy and hydrotherapy can be useful 
to help individuals with MPS III achieve specific and 
realistic goals in daily life. It can also help to drain 
mucus from the chest. 
Individuals should be as active as possible in order 
to improve their general health. A physiotherapist may 
be able to suggest ways of achieving this. The best forms 
of physiotherapy exercises are those that are introduced 
through play in the younger individuals. 
In adults it is important to remember that passive 
stretching maybe painful and should only be used with 
caution.
Medication 
Children with MPS may be affected differently by drugs 
so it is essential to consult your doctor rather than 
purchase over the counter medication. 
Drugs may be tried for controlling mucus production 
but some may make the mucus thicker and harder 
to dislodge. They may also make the child more irritable. 
The use of sedatives can increase the problem of sleep 
apnoea by depressing respiration.
It is now recognised that frequent use of antibiotics may 
make them less effective when really needed. 
Repeated use can also cause thrush, a fungal infection 
which commonly affects the mouth or vagina 
and produces a white curd-like deposit. 
It causes irritation and discomfort and will need 
to be treated. Your doctor may, therefore, wish to limit 
the number of times antibiotics are prescribed 
for coughs and colds.
Diet
Most children with MPS III have hearty appetites 
but if your child is faddy it can be difficult to achieve 
a balanced diet. Ask your doctor or dietician 
if supplementary vitamins should be given.
There is no scientific evidence that a particular diet 
has any beneficial effects. Symptoms such as diarrhoea 
tend to come and go naturally. Some parents, however, 
find that a change in their child’s diet can ease problems 
such as excessive mucus, diarrhoea and hyperactivity. 
Cutting down on milk, dairy products and sugar 
as well as avoiding foods with too many additives and 
colourings have all been said to help individual children.
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It would be advisable to consult your doctor or a dietician 
if you plan any major changes to ensure that the proposed 
diet does not leave out any essential nutriants. 
If your child’s problems are eased by a new diet you could 
try reintroducing foods one at a time to establish if there 
are any foods in particular that increase 
your child’s symptoms.
Feeding
Children’s early feeding very rarely causes problems, 
however, some do not progress to eating food that 
requires chewing.  Others learn to chew but increasingly 
find solid food difficult to manage. Children with 
MPS III can find lumps in food particularly difficult, 
especially if mixed with food of a smooth texture. 
The child may also become quite faddy and reject 
a number of foods for no particular reason.
Children may become very difficult to feed. If possible 
parents should encourage their child to take an active 
part in feeding themselves. This, as well as seeing 
and smelling their food, encourages them to prepare 
for the process of swallowing. Some parents find 
a musical box or the television calms their child during 
a meal. As children lose the rhythm of swallowing they 
may start to splutter and cough while eating. In addition, 
dribbling or drooling may be more obvious.  It is better 
to serve food of a mashed consistency. Meat will be coped 
with more easily if it is made soft through slow cooking 
rather than just chopped into small pieces. 
Thickeners added to liquids can often make swallowing 
drinks easier.  Moving the hand gently backwards under 
the chin and slowly down the throat can help the tongue 
to move and encourage swallowing.  
Choking is frightening so you can provide reassurance 
by rubbing your child’s back and holding hands.
Cold Hands & Feet
It cannot be said whether icy cold hands and feet are a 
feature of the disease or purely due to lack of activity. 
If this becomes a problem it may be beneficial for the 
child to wear warm socks and gloves. 
In the later stages of the disease the body’s natural 
temperature control mechanism may become damaged 
and the child may sweat at night and have cold hands 
and feet by day. Some children have epsodes when their 
body temperature drops (hypothermia). If this happens 
you should warm your child up and ask your doctor 
for advice on the best ways of managing the problem. 
Chewing
As they become more out of touch with their 
environment, many children with MPS III will amuse 
themselves by rocking or by chewing their fingers, 
clothes or whatever they can lay their hands on. 
As this behaviour cannot be stopped, it is best dealt 
with by providing an acceptable and interesting range 
of things to chew such as rubber toys or teething rings.
If the problem becomes so severe that the child is 
causing harm to their fingers and hands, it is possible 
to splint the elbows for periods of the day to prevent 
the hands from reaching the mouth.  
Hyperactive Behaviour
Most Sanfilippo children go through a hyperactive 
stage when they are difficult to control and unaware 
of danger. It is not so easy to modify this by drugs 
and it is better, if possible, to adapt the home 
(as described earlier). A garden where the child 
can run about safely is a great asset. It might be 
possible to get a grant for fencing if this is necessary 
to make it secure. It is most helpful if the child 
can get out to a playgroup or to school where a variety 
of activities can be provided. Children with MPS III 
do not concentrate for long periods of time and cannot 
be expected to sit still. Ideally there should be space 
for the child to run about and use up energy as well as 
keeping fit for as long as possible. Many children are 
calmed by the movement of a car and will travel well.
Gastrostomy
For some individuals swallowing will become 
increasingly difficult and unsafe. 
In these circumstances a gastrostomy is recommended. 
This is a tube placed in the stomach during a short 
operation. Most parents prefer a gastrostomy as this 
does not interfere with the airway or irritate the nose.
 
Although a gastrostomy requires a short general 
anaesthetic, there are usually no complications 
as long as the operation is done before the child 
becomes too frail. 
Gastrostomies can leak and occasionally the skin 
around the tube insertion becomes inflamed. 
You will be given advice from your surgeon on how 
to deal with this should the need arise.
Living with a Child with Sanfilippo Disease
Home Adaptations
During the hyperactive stages of MPS III parents find 
it very helpful if they can set aside a room or part 
of a room within hearing distance.  The room, 
which can be fitted with a half door latched 
on the outside, can be made safe for the child to play 
without constant supervision so that the parent can get 
on with day to day tasks in relative peace and quiet. 
Furniture which is fragile or that has sharp edges should 
be removed and replaced by large cushions or a mattress 
on the floor.  Windows may need to be fitted with 
strengthened glass and the floor should be easy to clean.  
The child’s favourite playthings and durable toys should 
be provided and a television can be placed on a high shelf 
or suspended from the ceiling. These could be operated 
by the parents using a remote control.
Children in the later stages of the disease will become 
progressively less mobile and increasingly dependent 
on their parents and carers to meet their everyday needs 
in areas of incontinence, personal hygiene and nutrition. 
It is important to give thought early on to the ways 
in which the families and carers will manage when weight 
bearing and walking or climbing the stairs is no longer 
possible. An ensuite bathroom for the child’s bedroom 
is ideal with plenty of space for a buggy and a carer to 
manoeuvre around in. When weight bearing is no longer 
possible a hoist is beneficial with tracking from bed 
to bath directly in line for ease of use. Adaptations can 
often take a long time so it is prudent to plan ahead as far 
as possible. The MPS Society has considerable experience 
of the options available to families caring 
for a child with MPS III. 
Education
Whilst some children with MPS III may benefit from having 
a mainstream education in their primary school years 
and enjoy the social interaction with peers, 
a majority will equally benefit from a Special Educational 
Needs Placement with small class sizes and a range 
of communication systems in place. Children with 
MPS III may have a Statement of Special Educational 
Needs or need an Individual Education Plan (IEP) with 
regular reviews. 
Many will need the help of a classroom assistant during 
the school day as well as during breaks and lunchtimes 
to ensure they are able to access all the educational 
opportunities open to them. This is also to maintain their 
health and safety throughout the day. 
This provision will enable the class teacher to set 
specific tasks for the child. The classroom assistant will 
be on hand to help keep the child on task and maintain 
concentration. Many individuals with MPSIII have a very 
short concentration span requiring them to be constantly 
kept on short tasks.
Having a Break
Caring for a child affected by MPS III is hard work 
and parents or carers need a break to rest and enjoy 
activities which may not be possible when in their caring 
role. Many families use children’s hospices; social services 
respite care or have someone close, such as a friend 
or family member, on hand to help out at busy times. 
Further details of hospices throughout the UK offering 
respite care to families are available from the MPS 
Society.
Palliative Care
Palliative care is provided to both the family and the child 
with a life limiting disease in situations where curative 
treatment is not an option. This support encompasses 
aspects such as respite care, symptom management 
and bereavement support and may extend over 
a considerable period of time.  In addition, considerable 
personal care may be required including feeding and 
personal hygiene. This can take up a large amount of 
time. The stress involved can put a family under immense 
strain. An assessment of medical needs and a care plan 
should lead to an approved package of support being 
provided to both the child and the family. Once in place 
this should enable both to experience a better quality 
of life. 
Sleeping Difficulties
Many Sanfilippo children are very restless at night, 
not sleeping for more than a couple of hours 
at a time. The reason for this is not known. 
It is sometimes possible to improve the situation with 
medication, but it may take a period of trial and error 
to establish which drug will work best for your child. 
Drugs often lose their effect after a while so some 
parents choose to either ration their use to a few 
nights a week or accept that after a few weeks 
the drug will have to be discontinued for a period. 
Some parents find they can achieve a longer period 
of unbroken sleep by putting the child to bed later 
and with a regular routine. It is vitally important that 
parents get enough sleep if they are to cope in the day, 
so do not hesitate to ask your doctor for help.
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Puberty
Children with MPS III will go through the normal changes 
associated with puberty, sometimes at an early stage. 
There are a number of ways of managing periods in older 
girls and you should ask your doctor for advice.
Life Expectancy
Whilst many children will loose their lives to MPSIII in 
their teenage years, a significant number will survive into 
adulthood. Survival into the 30s, 40s and even 50s 
is known.
Treatment of MPS III
At present there is no cure for MPS III. Various 
experimental methods have been used to try to replace 
the missing enzyme but none have proven to have any 
significant long term benefits. Bone Marrow Transplant has 
been tried on patients with MPS III but with disappointing 
results and is now never recommended for this condition.
About the MPS Society 
The Society for Mucopolysaccharide Diseases 
(MPS Society) was founded in 1982 representing over 1200 
children and adults suffering from MPS and related diseases 
including Fabry, their families, carers and professionals 
throughout the UK. It is a registered charity entirely 
supported by voluntary donations and fundraising and is 
managed by the members themselves.
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What is Hunter Disease?
Hunter Disease is a Mucopolysaccharide storage disorder 
also known as Mucopolysaccharidosis Type II (MPS II). 
Hunter Disease takes its name from Charles Hunter, 
a Professor of Medicine in Manitoba, Canada, who fi rst 
described two brothers with the disorder in 1917. 
In the past just two types of Hunter Disease have been 
described, mild and severe. It is now clear, however, 
based on current understanding of the enzyme and its 
gene, that Hunter Disease comprises a wide spectrum 
of severity. 
All individuals with Hunter Disease have a defi ciency 
of the enzyme ‘iduronate sulphatase’ which results 
in the accumulation of Mucopolysaccharides. 
The accumulation of Mucopolysaccharides is responsible 
for many problems that affect individuals with 
Hunter Disease. 
Whilst there is no cure for individuals affected 
by Hunter Disease, this fact sheet explores the disease’s 
presentation and clinical management. 
This fact sheet is produced by the 
Society for Mucopolysaccharide Diseases and draws 
on the experiences of parents and doctors with reference 
to medical literature.
What Causes Hunter Disease?
Mucopolysaccharides are long chains of sugar molecules 
used in the building of bones, cartilage, skin, tendons 
and many other tissues in the body. 
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“Muco” refers to the thick jelly like consistency of the 
molecules,“poly” means many and “saccharide” is a 
general term for a sugar molecule. An alternative word 
for Mucopolysaccharides is Glycosaminoglycans 
or GAGs but the term Mucopolysaccharide will be used 
for continuity throughout this fact sheet.
In the course of normal life there is a continuous 
recycling process of building new Mucopolysaccharides 
and breaking down old ones. 
The breakdown and recycling process requires a series 
of special biochemical tools called enzymes. 
Individuals with Hunter Disease are missing, or are 
defi cient in, an enzyme called ‘iduronate sulphatase’ 
which is essential in the breaking down of the 
Mucopolysaccharides called ‘dermatan’ and ‘heparan 
sulphate’. 
The incompletely broken down dermatan and heparan 
sulphate remain stored inside the cells of the body 
and begin to build up causing progressive damage. 
Babies may show little sign of the disease but as more 
and more cells become damaged by accumulation 
of Mucopolysaccharides, symptoms start to appear.
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Does Hunter Disease Aff ect Individuals 
Diff erently?
Until recently Hunter Disease had been described 
as either mild or severe. However, based on current 
understanding of the enzyme and its gene, Hunter Disease 
comprises a wide spectrum of severity. Some individuals 
with Hunter Disease will have progressive developmental 
delay and severe progressive physical problems. 
Others will have normal intelligence and progressive 
physical problems, some being more severely affected 
than others. 
It is important to remember that Hunter Disease 
is extremely varied in its effects. A whole range 
of possible symptoms are outlined in this factsheet, 
however, the affected individual may not experience 
all of them. Hunter Disease may even vary in its effects 
between siblings and generations.
How Common is Hunter Disease?
Except in very rare cases, only males will be affected 
by Hunter Disease. The MPS Society, which co-ordinates 
the European Registry for Mucopolysaccharide and related 
diseases, has shown that this is a rare condition affecting 
1 in 100,000 male births. 
Over a 10 year period, between 1992 and 2002, 52 babies 
with Hunter Disease were born in the United Kingdom.
How is Hunter Disease Inherited?
Hunter Disease has a different form of inheritance from 
all other MPS Diseases as it is an X-linked recessive disease 
(also called sex-linked) like haemophilia. 
Females may be carriers, but except in very rare cases 
only males will be affected. If a woman is a carrier 
for Hunter Disease there is a 50% (1:2) risk that any male 
born to her will have the disorder. Further more, 
there is a 50% (1:2) risk that any female born to her will 
be a carrier for the disorder. This means that there 
is a 25% (1:4) chance of having an affected child 
with each pregnancy. 
The sisters and maternal aunts of an individual with 
Hunter Disease may be carriers of the disorder and would 
also have a 50% risk of passing the abnormal 
gene to any male born to them. In many families 
it is possible to detect female carriers by direct analysis 
of genetic material. The doctor may wish to take a sample 
of blood from your affected child so that the exact genetic 
abnormality can be detected. In most families it is possible 
to identify the exact genetic fault on the X-chromosome 
responsible for Hunter Disease (mutation analysis). 
This can help with pre-natal diagnosis and carrier testing. 
However, the mother is not always found to be a carrier 
for Hunter Disease in all cases. In this situation the disorder 
may have occurred in the male for the fi rst time, 
a new mutation. 
There is a more detailed explanation of this complex subject 
in the booklet on inheritance available from the MPS Society.
Can you Test for Hunter Disease 
in Pregnancy?
There are three situations when pre-natal testing is possible  
in early pregnancy to detect Hunter Disease: 
•If you are already a mother to a child with Hunter Disease. 
•If you know you are a carrier.
•If you are a female relative on the mother’s side to a male 
with Hunter Disease and have not been carrier tested. 
It is important to contact your doctor when planning 
a pregnancy, or as soon as you suspect that you may 
be pregnant if you wish tests to be arranged. 
Both amniocentesis and chorionic villus sampling can 
be used to diagnose Hunter Disease in utero.
Genetic Counselling
All parents of children with a lysosomal storage disease 
should consider asking for genetic counselling before 
having other children. The counsellor should be able 
to provide non-directive advice on the risk to close relatives 
and the reproductive choices available as well as advice on 
whether the wider family should be informed.
Life Expectancy
There is a wide range of life expectancy depending 
on whether there is involvement of the Central Nervous 
System (CNS). Those individuals who do not have CNS 
involvement may have a reasonably normal life span if their 
physical problems, such as chest and heart disease, 
are not severe. 
Survival into the fi fth and sixth decades of life, however, 
is rare. Sadly, those who do have CNS involvement are likely 
to die before reaching their mid to late teens. Some children 
may die much earlier.
Clinical Presentation of Hunter Disease
Growth
Babies with Hunter Disease may be larger than average 
and may grow faster than normal during the fi rst two years 
of life. In individuals with severe Hunter Disease their fi nal 
height is likely to be between four feet (120cm) and four 
feet seven inches (140cm). Individuals with less severe 
Hunter Disease usually grow to a slightly less than normal 
height of 150-165cms (5 foot to 5 foot 6 inches).
Physical Appearance 
Individuals with Hunter Disease tend to bare a close 
resemblance to each other with many similar features. 
Their faces are often chubby with rosy cheeks and their 
heads are rather large with a prominent forehead. 
The neck is short and the nose is broad with 
a fl attened bridge. The lips are often thickened and the 
tongue enlarged. The hair tends to be thick, the eyebrows 
bushy and there may be more hair than usual on the body. 
Individuals with Hunter Disease have prominent bellies 
and a characteristic way of walking and holding their arms 
due to joint contractures at their hips, shoulders, elbows 
and knees.
Those in receipt of Enzyme Replacement Therapy (ERT) have 
noticed a marked improvement in certain characteristics 
including softening of the hair and facial features as well as 
a noticeable improvement in their height. Individuals have 
also noticed that their tummies are far less prominent due 
to the reduction in the size of the internal organs.
Intellectual Ability
Individuals with severe Hunter Disease usually experience 
progressive storage of Mucopolysaccharides in the brain 
that is primarily responsible for the slowing of intellectual 
development by 2 to 4 years of age. 
This is often followed by a gradual loss of skills until death; 
however the pattern is very varied.  Some individuals will 
only learn to say a few words while others learn to talk well 
and to read a little. They can enjoy nursery rhymes and 
simple puzzles. 
Emphasis should be on helping infants and children with 
Hunter Disease to learn as much as they can before 
the disorder progresses.
Even when the child starts to lose skills they have learned 
there may be some surprising abilities left. Children will 
continue to understand and fi nd enjoyment in life even 
if they lose the ability to speak. 
Individuals with less severe Hunter Disease may have normal 
intelligence. They usually have the same physical features as 
those seen in severe Hunter Disease, but with a reduced rate 
of progression.
Brain
The brain and the spinal cord are protected from jolting 
by the cerebrospinal fl uid that circulates around them. 
In some individuals with Hunter Disease the circulation 
of the fl uid may become blocked over time. 
The blockage (communicating hydrocephalus) causes 
increased pressure in the head which can press on 
the brain. If this remains untreated it will result in 
headaches, visual impairment and delayed development. 
Other aspects of Hunter Disease that can affect brain 
function include inadequate oxygen levels and sleep 
deprivation due to sleep apnoea.
Eyes
Clouding of the cornea, which is a feature of some of the 
other MPS diseases, is not normally found in individuals 
with Hunter Disease. Occasionally there may be problems 
with vision caused by changes to the retina or glaucoma 
(due to increased fl uid pressure inside the eye) which 
should be checked during an eye examination. Storage in 
the retina can result in loss of peripheral vision and night 
blindness.
Ears 
Some degree of deafness is common in individuals 
suffering from Hunter Disease. It may be Conductive 
Deafness, Nerve Deafness or both (Mixed Deafness) 
and may be made worse by frequent ear infections. 
It is important that individuals with Hunter Disease 
have their hearing checked regularly and for problems 
to be treated early to improve or maintain the ability 
to communicate. 
Correct functioning of the middle ear depends on the 
pressure behind the ear drum being the same as that 
in the outer ear canal and the atmosphere. This pressure 
is equalised by the eustachian tube which runs from the 
middle ear to the back of the nose. If the tube is blocked, 
the pressure behind the eardrum will drop and the drum 
will be drawn in. If this negative pressure persists, fl uid 
from the lining of the middle ear will build up and in time 
become thick like glue. Hence the condition being known 
as “glue ear”. 
Epilepsy
A number of individuals who are severely affected 
by Hunter Disease will develop epilepsy. This may take 
different forms, e.g. absence episodes (where the 
individual may appear to be staring into space with 
or without jerking or twitching movements of the eye 
muscles), or more generalised tonic-clonic seizures 
(a type of generalized seizure that affects the entire 
brain). Tonic-clonic seizures are more commonly 
associated with epilepsy. Fortunately most individuals 
will respond favourably to anticonvulsant medication.
Night Blindness
Many families have reported that children with 
Hunter Disease do not want to walk in the dark 
or are afraid when waking up at night. 
Sometimes the simple addition of a night light in a hall 
or bedroom may prove benefi cial. It is often diffi cult 
to determine what is responsible for this problem.
Hydrocephalus
Hydrocephalus (also known as ‘water on the brain’) can 
be confi rmed using a CT or MRI scan. A lumbar puncture 
(known as a spinal tap) with pressure measurement 
is another way to assess if hydrocephalus exists. 
If hydrocephalus is confi rmed it can be treated by 
insertion of a thin tube (shunt) which drains fl uid from 
the brain. The shunt has a pressure sensitive valve 
which allows spinal fl uid to be drained when 
the pressure around the brain becomes too high. 
A lack of swelling around the optic disc does not rule 
out hydrocephalus in an individual suffering from 
Hunter Disease.
Nose & Throat 
Typically, the bridge of the nose is fl attened 
and the passage behind the nose is smaller than usual 
due to poor growth of the bones in the mid-face 
and thickening of the mucosal lining. 
The combination of abnormal bones and storage 
of Mucopolysaccharide in the soft tissues in the nose 
and throat can cause the nose to become easily blocked. 
One of the common features of children with 
Hunter Disease is the chronic discharge of clear mucus 
from the nose (rhinorrhea), and sinus infections.
Frequent coughs, colds and throat infections are common 
problems for many individuals with Hunter Disease. 
Individuals will have narrowing of the large airways 
and increased secretions which can lead to ‘asthma-like’ 
episodes. Many individuals with Hunter Disease are helped 
by treatment of asthma medication during viral illness.
Many affected individuals breathe very noisily, 
even when there is no infection. At night they may 
be restless and snore. Admission to hospital overnight 
for a sleep study may be advised. Monitors are placed 
on the skin and connected to a computer. 
These monitors measure brain waves, the levels of oxygen 
in the blood and the breathing effort that is required 
during sleep. From this study doctors can assess how 
much blockage to breathing is present, how much trouble 
your child is having moving air into the lungs during sleep 
and how much of an effect this has on their body. 
Removal of tonsils and adenoids may help in some cases 
to lessen the obstruction and make breathing easier, 
but adenoid tissue may grow back.
The windpipe (trachea) becomes narrowed by storage 
material and is often more fl oppy, or softer than usual 
due to abnormal cartilage rings in the trachea. 
Nodules or excess induration of tissue can further block 
the airway making swallowing diffi cult.
Mouth & Teeth
Individuals with Hunter Disease usually have thicker 
lips and an enlarged tongue. Gum ridges are broad. 
The teeth are widely spaced and poorly formed with 
fragile enamel.
Dental Hygiene
It is important that the teeth are well cared 
for to avoid the need for extractions. If the water 
in your area has not been treated with fl uoride, 
a child with Hunter Disease should have fl uoride tablets 
or drops daily. Cleaning around the mouth 
with a small sponge or a stick soaked in mouthwash 
will help keep the mouth fresh and avoid bad breath. 
Dribbling is a common problem and a plastic-backed 
bib under the clothes may prevent soreness. 
Regular checks at the dentist are important as tooth 
decay could be a source of pain. If your child is 
severely affected it may be safer for treatment to be 
carried out at a hospital. 
It is important that you inform the dentist if your 
child has a heart problem. You will probably be advised 
that s/he should be given antibiotics before and after 
any dental treatment. This is because certain bacteria 
in the mouth may get into the blood stream and cause 
an infection on the heart valves. If teeth need to be 
removed under anaesthetic, this should be carried 
out in a hospital under the care of an experienced 
anaesthetist and never in the dental surgery. 
It may be possible for the hospital to carry out 
other treatment or investigations under the same 
anaesthetic.
Sensorineural Deafness (Nerve Deafness)
In most cases the cause of Nerve Deafness 
is damage to the tiny hair cells in the inner ear. 
It may accompany Conductive Deafness, in which 
case it is referred to as Mixed Deafness. 
Nerve Deafness is managed by the fi tting of hearing 
aids in most individuals with Hunter Disease. 
More severely affected children may keep pulling 
out their hearing aids at fi rst but it is important 
to persevere at wearing them so that communication 
can be maintained. Other children with Hunter Disease 
have found radio aids and the loop system helpful 
at school and at home.
Night-time C-PAP 
A Night-time CPAP may be recommended where a sleep 
study has shown that an individual is experiencing 
sleep apnoeas with low oxygen levels at night. 
Sleep apnoea is where the individual stops breathing 
for short periods during sleep. This leads to daytime 
drowsiness and headaches.
C-PAP involves placing a mask or canula 
on the face each night and having air pumped 
into the airway to prevent it from collapsing. 
This may seem to be an extreme measure 
but it can greatly improve the quality of sleep 
as well as help prevent or reduce the risk of heart 
failure caused by low oxygen levels at night.
In severe cases of sleep apnoea with heart failure, 
a tracheostomy (a hole in the airway made in front 
of the neck) may be needed. Most individuals with 
Hunter Disease will try to avoid a tracheostomy 
because it is invasive and seemingly destructive 
of normal function. In fact those who have received 
an early tracheostomy claim to feel much better after 
improving their night time breathing.
Conductive Deafness (Glue Ear)
Under general anaesthetic a small incision behind 
the eardrum can be made (myringotomy) and the fl uid 
sucked out. A small ventilation tube called 
a “grommet” may then be inserted to keep the hole 
open and allow air to enter from the outer ear canal 
until the eustachian tube starts to work properly again. 
Grommets will eventually fall out. If the Conductive 
Deafness recurs the surgeon may decide to use T-tubes 
(a type of grommet which stays in place much longer). 
In view of the anaesthetic risks for individuals with 
Hunter Disease, the surgeon may decide to use T-tubes 
on the fi rst occasion.
Chest & Respiratory Infections
The shape of the chest is abnormal and the junction 
between the ribs and the breastbone (sternum) is not 
as fl exible as it should be. The chest is therefore rigid 
and unable to move freely to allow the lungs to take 
in a large volume of air. 
The muscles at the base of the chest (diaphragm) may be 
pushed upwards by an enlarged liver and spleen, further 
reducing the space for the lungs. When the lungs are not 
fully cleared, there is an increased risk of respiratory 
infections that may lead to pneumonia.
Heart 
Heart Disease is fairly common in individuals with 
Hunter Disease but may not develop or cause problems 
until much later in life. The heart may be affected 
in different ways. The valves, which open and shut 
as the blood is pumped from one chamber of the heart 
to another, may be weakened by storage 
of Mucopolysaccharides. The valves may fail to close 
tightly enough allowing small amounts of blood 
to leak back again. The muscles of the heart may 
also be damaged by storage of Mucopolysaccharides 
(cardiomyopathy) and the heart may be put under strain 
by upper airway obstruction, repeated chest infections 
or by having to pump blood through stiffened lungs 
(cor pulmonale).
Liver, Spleen & Abdomen 
In most individuals with Hunter Disease both the 
liver and spleen become enlarged by storage of 
Mucopolysaccharides (Hepatosplenomegaly). 
The enlarged liver does not usually cause liver problems 
or lead to liver failure, but it can interfere with eating 
and breathing. 
In individuals with Hunter Disease, the abdomen bulges 
out due to posture, weakness of the muscles and the 
enlarged liver and spleen. 
Frequently, part of the abdominal contents will push 
out behind a weak spot in the wall of the abdomen. 
This is called a hernia.
Respiratory Infections 
Medication may affect individuals with MPS differently, 
so it is essential to consult your doctor rather than using 
‘over the counter’ medication. 
Medication for controlling mucus production may 
not help. Medication such as antihistamines may 
dry out the mucus making it thicker and harder 
to dislodge. Decongestants usually contain stimulants 
that can raise blood pressure and narrow blood vessels, 
both undesirable for individuals with Hunter Disease.
Cough medicines that have a sedating effect may cause 
more problems with sleep apnoea by depressing muscle 
tone and respiration. 
Individuals with Hunter Disease commonly end up with 
secondary bacterial infections which should be treated 
with antibiotics.
Heart Problems 
Some individuals with Hunter Disease may develop 
problems with the aortic or mitral valve: they may 
have slowly progressive valvular Heart Disease for years 
without any apparent clinical effects. If the condition 
worsens an operation may be needed to replace the 
damaged valves. As heart problems occur so frequently 
in individuals with Hunter Disease, a test known as an 
‘echocardiogram’ should be carried out annually (or as 
often as your doctor thinks necessary) to show whether 
any problems are developing. The test is painless and 
similar to the ultra sound screening of babies in the 
womb. It can identify problems with heart muscle, 
heart function and heart valves.
Hernias
The hernia can come from behind the navel 
(umbilical hernia) or from the groin (inguinal hernia). 
Inguinal hernias should be repaired by an operation. 
Umbilical hernias are not usually treated unless they 
are large and cause entrapment of the intestine, or are 
very large and are causing other problems. 
It is very common to have a recurrence of both inguinal 
and umbilical hernias after a repair has been made.
Bowel Problems 
Many individuals with Hunter Disease suffer frequently 
or periodically from loose stools and diarrhoea. 
The cause of this is not fully understood. 
Occasionally the problem is caused by severe 
constipation and leakage of loose stools from behind 
the solid mass of faeces. More often however, parents 
describe it as “coming straight through”. 
It is thought that there may be a defect in the 
autonomic nervous system (the system that controls 
those bodily functions) usually beyond voluntary 
control. An examination by the paediatrician 
or physician, supplemented by an X-ray if necessary, 
will establish which is the cause. 
The problem may disappear as the child with 
Hunter Disease gets older, but it can be made worse 
by antibiotics prescribed for other problems. 
If there is diarrhoea (and it is not secondary to 
constipation) simple medication, for example 
loperamide (Imodium) can be very useful. 
A diet low in roughage may also be helpful. 
Constipation may increasingly become a problem 
as a child with Hunter Disease gets older, less active 
and the muscles progressively weaken. 
If an increase in roughage in the diet does not help 
or is not possible, the doctor may prescribe laxatives 
or a disposable enema.
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Skin
Individuals with Hunter Disease tend to have thickened 
and tough skin which lacks elasticity. This can cause 
irritation and soreness, particularly in areas where 
the skin folds i.e at the back of the neck. 
Some individuals with Hunter Disease have 
a characteristic pebble-like texture to their skin. 
These small skin-coloured bumps around the shoulder 
blades, upper arms and thighs are caused by storage of 
Mucopolysaccharides (nodular skin lesions).
Excess hair on the face and back occurs in some 
individuals with Hunter Disease. Sweating and cold 
hands and feet are also common problems due to poor 
temperature control, as the centre of the brain which 
regulates the temperature becomes damaged.
Bones & Joints
Individuals with Hunter Disease tend to have signifi cant 
problems with bone formation and growth. This leads 
to both bone and neurological problems if nerves are 
compressed by bone. 
Joint stiffness is a common feature of Hunter Disease 
and the maximum range of movement of all joints may 
become limited. Joint stiffness may cause pain, which 
may be relieved by warmth and ordinary painkillers. 
The limited movement in the shoulders and arms may 
make dressing diffi cult. Anti-infl ammatory drugs, 
such as ibuprofen, can help with joint pain, but they 
should be taken with or after food and monitored closely 
under medical supervision to make sure that irritation 
and ulcers of the stomach do not occur. 
Spine
The bones of the spine (vertebrae) normally line up from 
the neck to the buttocks. Individuals with Hunter Disease 
can have poorly formed vertebrae that may not stably 
interact with each other. One or two of the vertebrae 
in the middle of the back are sometimes smaller than 
the rest and set back in line. 
This backward slippage of the vertebrae can cause an 
angular curve (kyphosis or gibbus) to develop, but is 
usually mild and generally does not need treatment. 
Older children and adults with Hunter Disease 
occasionally develop compression of the spinal cord 
due to thickening of the ligaments around the bones 
of the neck. The doctor will want to monitor this carefully 
and arrange surgical treatment if necessary.
Hands
The shape of the hand is very characteristic and the 
MPS Society’s logo depicts the hands of a boy with 
Hunter Disease. The hands are broad with stubby fi ngers 
which gradually curve over or become clawed. 
Individuals with Hunter Disease often experience pain
and loss of feeling in the fi ngertips caused by 
Carpal Tunnel Syndrome. The wrist (or carpus) consists 
of eight small bones known as the carpals which 
are joined by fi brous bands of protein called ligaments. 
Nerves have to pass through the wrist in the space 
between the carpal bones and the ligaments. 
Thickening of the ligaments causes pressure 
on the nerves. This can cause irreversible nerve damage. 
The nerve damage will cause the muscle at the base 
of the thumb to waste away. 
Legs & Feet 
Many individuals with Hunter Disease stand and walk with 
their knees and hips fl exed. This, combined with the tight 
achilles tendon, may cause them to walk on their toes. 
Sometimes these individuals have knocked knees but this 
is very unlikely to need treatment. The feet are broad 
and may be stiff with the toes curved under, rather like 
the hands.
General Management of Hunter Disease 
Anaesthetic 
Giving an anaesthetic to an individual with Hunter Disease 
requires skill and should always be undertaken 
by an experienced anaesthetist. 
Where a child is concerned this should be a paediatric 
anaesthetist. 
The airway can be very small and may require a very 
small endotracheal tube. Placing the tube may prove 
diffi cult and require the use of a fl exible bronchoscope. 
In addition, the neck may be somewhat lax and 
repositioning the neck during anaesthesia or intubation 
could cause injury to the spinal cord. 
Carpal Tunnel Syndrome
Although a child or adult with Hunter Disease may not 
complain of pain they may already have Carpal Tunnel 
Syndrome. Doctors may advise for this to be monitored 
with a test called a nerve conduction study which will 
show whether there is carpal tunnel syndrome present. 
This test would also be carried out if there is any 
weakness or numbness in the hand or decreased muscle 
mass at the base of the thumb. This disorder can be 
treated by a minor operation.
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For some individuals, it is diffi cult to remove 
the breathing tube after surgery is completed. 
There is a more detailed explanation of this complex 
subject in the specialist anaesthetic booklet published by 
the MPS Society.
Physiotherapy & Hydrotherapy 
Physiotherapy and Hydrotherapy can be useful to help 
individuals with Hunter Disease achieve specifi c and 
realistic goals in daily life or to drain mucus from the 
chest. At other times it is common sense for the
individuals to be as active as possible to improve their 
general health and the physiotherapist may be able 
to suggest ways of achieving this. For younger individuals 
the best forms of physiotherapy are exercises that 
are introduced through play. In adults it is important 
to remember that passive stretching may be painful 
and should only be used with caution. 
Living with a Severely Aff ected Child 
or Adult with Hunter Disease 
Children with Hunter Disease may be overactive, strong, 
usually cheerful and affectionate but hard work to look 
after. They have limited powers of concentration and less 
understanding than you would expect for their age and 
physical development. They could, for example, lock the 
bathroom door but be unable to understand how to get 
out again, even when told. They enjoy rough and tumble 
play, making a lot of noise and throwing toys rather than 
playing with them. They may be unaware of danger, 
stubborn and unresponsive to discipline as they cannot 
understand what is required. Some may have outbursts 
of aggressive behaviour. Toilet training may be achieved 
briefl y by some individuals but most will remain in 
nappies. Getting enough sleep may be diffi cult for parents 
who should not hesitate to ask their doctors for help. 
Feeding
Most children with Hunter Disease enjoy their food, 
although some will eat only a very limited range of foods. 
They often drink a great deal. Many do not progress 
to using a knife and fork or an ordinary cup 
and eventually it may be necessary to feed your child 
as you would a baby. In the later stages, your child may 
fi nd it harder to chew properly and food may have 
to be mashed or liquidised. 
When a child or adult cannot chew and has diffi culty 
swallowing, there is a risk of choking. Food, especially 
meat, should be cut up very small, but even this may not 
prevent the possibility of choking. For some individuals, 
swallowing will become increasingly diffi cult and in these 
circumstances a gastrostomy may be recommended.
Education
Whilst some children with severe Hunter Disease may 
benefi t from having a mainstream education in their 
primary school years and enjoy the social interaction 
with peers, a majority will equally benefi t from a Special 
Educational Needs placement with small class sizes 
and a range of communication systems in place. 
Children with Hunter Disease may have a statement of 
Special Educational Needs or need an Individual Education 
Plan (IEP) with regular reviews. Many will need the help 
of a classroom assistant.
Home Adaptations
Children and adults with severe Hunter Disease will 
become progressively less mobile and increasingly 
dependent on their parents and carers to meet their 
everyday needs in areas of incontinence, personal 
hygiene and nutrition. 
It is important to give thought early 
on to the ways in which the families and carers will 
manage when weight bearing and walking or climbing 
the stairs is no longer possible. 
The MPS Society has considerable experience of the 
options available to families caring for an individual with 
severe Hunter Disease. 
Having a Break 
Caring for an individual severely affected by Hunter 
Disease is hard work and parents or carers need a break 
to rest and enjoy activities which may not be possible 
when in their caring role. 
Many families use children’s hospices, social services 
respite care and/or have a friend or family member 
close by that is available on a regular basis to help 
at busy times. 
Gastrostomy
For some individuals swallowing, and therefore eating 
and drinking, will become increasingly diffi cult 
and unsafe. In these circumstances a gastrostomy would 
be recommended. This is a tube (called a nasogastric 
tube) that is placed in the stomach during a short 
operation. Most parents prefer a gastrostomy as this 
does not interfere with their airway or irritate the 
nose. 
Although a gastrostomy requires a short general 
anaesthetic, as long as the operation is done before 
the child becomes too frail there are usually no 
complications. Gastrostomies can leak and occasionally 
the skin around the tube insertion may become 
infl amed. If this happens you will be given advice on 
how to deal with this from your surgeon.
The Quieter Stage 
The change from the overactive, noisy period is likely 
to be gradual. Families will realise that their affected 
child no longer runs everywhere and is happier sitting 
than standing. Many will be easily pleased, perhaps 
by looking through the same little book of photographs, 
having stories read or watching the same video many 
times over. Children and adults with Hunter Disease 
may doze off quite often. 
Weight will be lost gradually as muscles waste away and
chest infections may be more frequent. Many affected 
individuals die peacefully after an infection or from 
the heart’s gradual failure. Family and friends may fi nd 
it helpful to prepare for the time of death. 
If you feel you would like to do this please contact the 
MPS Society who have information you may fi nd helpful.
Living with a Less Severely Aff ected Child or 
Adult with Hunter Disease 
Less severely affected children suffering from 
Hunter Disease may be completely normal in behaviour 
and they are often affectionate, sunny natured children.
 
They can be short tempered at times from frustration 
when their physical limitations make life diffi cult. 
Independence
As a child with Hunter Disease grows up they should 
be encouraged to be as independent as possible since 
many adults with Hunter Disease can live full
and enjoyable lives. The teenage years may be diffi cult: 
if ordinary adolescents worry about a pimple on the chin, 
think how much more teenagers with Hunter Disease 
must worry about their appearance and the restrictions 
imposed by their condition. They may be helped 
by meeting or being in touch with other teenagers 
and adults with Hunter Disease. Ask the MPS Society to 
put you in touch through their Befriending Scheme. 
Those who are less severely affected by Hunter Disease 
will go through the normal stages of puberty but possibly 
a year or so after their peers. 
Home Adapations
Appropriately adapted living accommodation will greatly 
enhance the ability of an individual with Hunter Disease 
to develop independent living skills. A few less severely 
affected adults with Hunter Disease have found satisfying 
work as social workers, civil servants, teachers of the 
deaf and one is known to be a marine architect. 
There is every reason to encourage a young person with 
Hunter Disease to lead as full and as independent a life 
as possible. 
The Future
A few adults with Hunter Disease have married 
and had children. The sons would not have Hunter Disease 
unless the mother happens to be a carrier. 
Daughters of a father with Hunter Disease will all be 
carriers of the disease.
Speciﬁ c Treatments for Hunter Disease 
Bone Marrow Transplant (BMT) 
For some years Bone Marrow Transplants (BMT) have been 
used to treat children with Mucopolysaccharide 
and related diseases but this procedure is currently not 
recommended for children with Hunter Disease. Bone 
Marrow Transplant in Hunter Disease has not been shown 
to have any effect on preventing the damage to the brain 
that occurs in individuals severely affected.
Enzyme Replacement Therapy (ERT)
Enzyme Replacement Therapy (ERT) for Hunter Disease 
has undergone a number of clinical trials and is now 
available for affected individuals. This therapy is based 
on the principle that the recombinant form of the enzyme 
that is missing or malfunctioning is given via repeated 
intravenous infusion in order to reduce the symptoms 
and clinical manifestations associated with the disease. 
This involves the recombinant enzyme being given 
by repeated intravenous infusion every week. 
ERT will help some of the physical problems associated 
with Hunter Disease, but unfortunately the ‘blood-brain 
barrier’ prevents the medication from directly helping 
the brain. As a result, the enzyme infusions do not lead to 
improvement in those who have Central Nervous System 
involvement.
ERT has demonstrated benefi ts in energy levels, reduction 
in the size of the liver and spleen, walking ability and 
lung function tests over a period of 12-18 months. 
In the longer term it is hoped that ERT will encourage 
the stabilisation of the physical condition and will 
continue to show an improvement within the quality 
of life in most individuals. 
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Future Treatments
There is a great deal of research being carried out that 
may lead to other treatments in the future.
As previously indicated, ERT poses a challenge 
in successfully introducing enzyme into the brain cells. 
To try and get round this in an attempt to develop 
a treatment for patients with severe MPS II, research 
workers are looking at the possibility of giving 
the enzyme directly into the fl uid around the brain; 
so called intra-thecal (IT) therapy. 
It has been proposed that, if suffi cient enzyme is infused 
by this route, a small quantity may cross the blood-
brain barrier and enter the brain. Initial studies have 
commenced in the USA but there are currently no results 
available.
Gene therapy, which is the concept of replacing the faulty 
gene with a copy of a normal gene, may be a realistic 
possibility in years to come. Experiments on animals 
with MPS II suggest that this may be a successful route 
of treatment in the future however; it is possible that 
not all those affected by Hunter Disease will be able 
to benefi t from these advances. 
Your paediatrician or physician may be able to give you 
up to date information on treatment options.
You can also contact the MPS Society.
About the MPS Society
The Society for Mucopolysaccharide Diseases
(MPS Society) was founded in 1982 and represents over 
1200 children and adults suffering from MPS and related 
diseases including Fabry, their families, carers and 
professionals throughout 
the UK.
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